Research reading
Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale demand and the Switzerland (CHE) to Kenya (KEN) lane
Kenya (KEN) reported $17.7M of medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale imports in 2024. Switzerland (CHE) accounted for 0.2% of the observed market and reported $40.6K in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +15.8% buyer growth and +6.7% exporter growth. The page separates reported values from projections and indicators.
